Scalable solutions for the future of gene therapies
Gene therapies hold immense promise, but their potential is hindered by limited accessibility driven by high production costs, complex processes, and infrastructure challenges. This white paper explores how Univercells Technologies’ integrated, intensified, and automated manufacturing solutions can help overcome these barriers. Drawing on expert insights and real-world data, it outlines a new path to democratizing gene therapies globally.
Learning points
- Why current gene therapy manufacturing approaches limit access and scalability
- How process intensification and closed, automated systems reduce cost and complexity
- A framework for designing fit-for-purpose manufacturing facilities in emerging markets
- Key considerations for aligning regulatory, technical, and commercial strategies
- Practical examples of how Univercells Technologies is enabling global accessibility